Home | Login | Join | Sitemap | °ü¸®ÀÚ¿¡°Ô
  • ÇÐȸ ¼Ò°³
  • Á¶Á÷µµ
  • ÀÓ¿øÁø
  • ¿ª´ëÀÓ¿øÁø
  • ÆòÀÇ¿ø
  • ÇÐȸ ȸĢ
  • Çмú´ëȸ ¾È³»
  • °ü·Ã Çà»ç ¾È³»
  • Çмú´ëȸ ¿¬Çõ
  • Çмú´ëȸ ÀÚ·á
  • Åõ°í±ÔÁ¤
  • ³í¹®Åõ°í
  • ÇÐȸÁö °Ë»ö
  • ÇÐȸ ¼Ò½ÄÁö
  • ÀϹÝÀÎÀ» À§ÇÑ Áúȯ Á¤º¸
  • ±âŸÀÚ·á½Ç
  • º´¿ø ã±â
  • ÇÐȸ ¼Ò½Ä
  • ȸ¿ø °Ô½ÃÆÇ
  • ȸ¿ø ÀÚ·á½Ç
  • À§¿øȸ °ø°£
  • ȸ¿ø °Ë»ö
  • ÇÐȸ ¾Ù¹ü
Åõ°í±ÔÁ¤
³í¹®Åõ°í
ÇÐȸÁö °Ë»ö
- ÇÐȸÁö »ó¼¼°Ë»ö
- ÇÐȸÁö ±ÇÈ£º°°Ë»ö
ÇÐȸ ¼Ò½ÄÁö
HOME > °£Ç๰ > ÇÐȸÁö °Ë»ö
Korean Journal of Neuromuscular Disorders ; 14 : 23 - 29, December 2022
A Practical Review of Paraproteinemic Neuropathy
Down
Joong-Yang Cho, MD
Department of Neurology, Ilsan Paik Hospital, Inje University College of Medicine

Paraproteinemic neuropathy is a heterogeneous set of neuropathies
characterized by the presence of homogeneous immunoglobulin in the
serum. Most cases are associated with monoclonal gammopathy of
undetermined significance. It might also occur in hematologic
malignant and nonmalignant conditions. The association between
neuropathy and monoclonal gammopathy requires appropriate
neurological and hematological investigations. Treatment is mostly
based on underlying hematologic disorders. In this review, we
provide a clinically practical approach to clinical, laboratory,
electrophysiological features and management of patients with
paraproteinemic neuropathy.

KEYWORDS : Paraproteinemia, Monoclonal gammopathy, Neuropathy

°Ô½Ã¹°¸ñ·ÏÀ» º¾´Ï´Ù.
(03163) ¼­¿ï Á¾·Î±¸ Àλ絿±æ 12, 1111È£ (Àλ絿, ´ëÀϺôµù)
TEL : 02-720-1594 E-mail : knmd1594@daum.net
Copyright©The Korean Society of Neuromuscular Disorders
TODAY 57 TOTAL 545821